152 related articles for article (PubMed ID: 27146810)
1. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
Li T; Tang W; Zhang L
Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
[TBL] [Abstract][Full Text] [Related]
2. Predicting pathway cross-talks in ankylosing spondylitis through investigating the interactions among pathways.
Gu X; Liu CJ; Wei JJ
Braz J Med Biol Res; 2017 Nov; 51(1):e6698. PubMed ID: 29160414
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel targets for multiple myeloma through integrative approach with Monte Carlo cross-validation analysis.
Liu C; Gu X; Jiang Z
J Bone Oncol; 2017 Sep; 8():8-12. PubMed ID: 28856086
[TBL] [Abstract][Full Text] [Related]
4. Integrating differential pathway analysis with Monte Carlo cross-validation reveals seed cross-talks in non-small cell lung carcinoma.
Zheng ML; Zhou NK; Luo CH
J BUON; 2016; 21(5):1203-1209. PubMed ID: 27837624
[TBL] [Abstract][Full Text] [Related]
5. Identification of significant pathway cross-talk in rheumatoid arthritis by the Monte Carlo cross-validation method.
Song W; Zhang YM; Ma T; Wang J; Wang KZ
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387872
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: A preliminary study.
Zheng ML; Zhou NK; Luo CH
Microb Pathog; 2016 Nov; 100():78-83. PubMed ID: 27616444
[TBL] [Abstract][Full Text] [Related]
7. Pathway analysis based on Monte Carlo Cross-Validation in polyarticular juvenile idiopathic arthritis.
Lin S; Wang Y; Mu S; Zhang J; Yuan F; Sun K
Pathol Res Pract; 2017 Jan; 213(1):7-12. PubMed ID: 27894617
[TBL] [Abstract][Full Text] [Related]
8. Application of Monte Carlo cross-validation to identify pathway cross-talk in neonatal sepsis.
Zhang Y; Liu C; Wang J; Li X
Exp Biol Med (Maywood); 2018 Mar; 243(5):444-450. PubMed ID: 29513099
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
Colaprico A; Cava C; Bertoli G; Bontempi G; Castiglioni I
Biomed Res Int; 2015; 2015():831314. PubMed ID: 26240829
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling predicts pathways and genes associated with Parkinson's disease.
Liu S; Zhang Y; Bian H; Li X
Neurol Sci; 2016 Jan; 37(1):73-79. PubMed ID: 26269422
[TBL] [Abstract][Full Text] [Related]
11. Personalized Analysis by Validation of Monte Carlo for Application of Pathways in Cardioembolic Stroke.
Xing Z; Luan B; Zhao R; Li Z; Sun G
Med Sci Monit; 2017 Feb; 23():994-1000. PubMed ID: 28232661
[TBL] [Abstract][Full Text] [Related]
12. Revealing hub pathway cross-talk for premature newborns with bronchopulmonary dysplasia by the integration of pathway analysis and Monte Carlo Cross-Validation.
Wang C; Zhu B; Chen M; Chen G; Xu M; Pan R
Exp Ther Med; 2019 Apr; 17(4):2715-2719. PubMed ID: 30930971
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Dysregulated Networks in Individual Patients with Ischemic Stroke Based on Monte Carlo Cross-Validation.
Sun G; Luan B; Zhao R; Li Z; Xing Z
DNA Cell Biol; 2016 Dec; 35(12):795-801. PubMed ID: 27726417
[TBL] [Abstract][Full Text] [Related]
14. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential diagnostic biomarkers for Parkinson's disease.
Jiang F; Wu Q; Sun S; Bi G; Guo L
FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
[TBL] [Abstract][Full Text] [Related]
16. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
Kelly J; Moyeed R; Carroll C; Albani D; Li X
Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
Wang C; Chen L; Yang Y; Zhang M; Wong G
Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
[TBL] [Abstract][Full Text] [Related]
18. Gene set enrichment analysis of pathways and transcription factors associated with diabetic retinopathy using a microarray dataset.
He K; Lv W; Zhang Q; Wang Y; Tao L; Liu D
Int J Mol Med; 2015 Jul; 36(1):103-12. PubMed ID: 25997411
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential drugs for Parkinson's disease based on a sub-pathway method.
Sun AG; Lin AQ; Huang SY; Huo D; Cong CH
Int J Neurosci; 2016; 126(4):318-25. PubMed ID: 25405535
[TBL] [Abstract][Full Text] [Related]
20. Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.
Zhou T; Zhang Y; Wu P; Sun Q; Guo Y; Yang Y
Int J Rheum Dis; 2014 Jul; 17(6):671-8. PubMed ID: 24867262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
